Sickle Cell Disease

Sickle cell disease (SCD) is a complex group of inherited blood disorders associated with debilitating pain and complications that can affect the entire body. SCD affects about 100,000 people in the United States; more than 90% are non-Hispanic Black or African American, and an estimated 3%-9% are Hispanic or Latino.

Through evidence-based resources and targeted information, the U.S. Department of Health and Human Services (HHS) Office of Minority Health (OMH) is supporting organized systems of care that help individuals and families affected by SCD live longer, healthier lives and support the Administration’s mission to Make America Healthy Again.

Happy family gathered together on couch.

SCD Basics, Resources, News, and Therapies

Promoting Good Nutrition in People with Sickle Cell Disease | HHS OMH Blog

What is Sickle Cell Disease? | National Heart, Lung, and Blood Institute

Sickle Cell Disease | Medline Plus

Sickle Cell Disease Topic Guide | HHS OMH Knowledge Center

Steps to Better Health Toolkit | Centers for Disease Control and Prevention

Sickle Cell Disease Gene Therapy Education Project | National Institutes of Health’s National Human Genome Research Institute

Cell and Gene Therapy (CGT) Access Model | Centers for Medicare and Medicaid Services

FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease (press release) | U.S. Food and Drug Administration

Sickle Cell Disease (YouTube playlist) | U.S. Department of Health and Human Services

Observances and Events

May 14 and June 18, 2026: Understanding the Requirements for Sickle Cell Disease Comprehensive Systems of Care
Join HHS OMH for a two-part roundtable series focused on advancing comprehensive systems of care for sickle cell disease (SCD). A comprehensive system of care for SCD offers multidisciplinary and specialized healthcare services to the SCD community throughout the lifespan. Participants will learn about and discuss key components of comprehensive SCD care, current challenges, and emerging best and promising practices.

“Understanding the Requirements for Sickle Cell Disease Comprehensive Systems of Care” will engage SCD warriors, healthcare providers, community organizations, advocates, and federal partners to identify core needs and priorities for comprehensive SCD systems of care and to explore opportunities for coordination and collective action.

Part 1 is scheduled for Thursday, May 14, 2026, from 2:00 PM to 3:30 PM ET. The objectives for Part 1 are to:

  • Identify key elements, current challenges, and emerging best practices of a comprehensive system of care for SCD, including the role of nutrition.
  • Raise awareness about current activities and policies related to comprehensive systems of care for SCD.

Register for Part 1 today.

Past 2 is scheduled for Thursday, June 18, 2026. More details about Part 2, including how to register, will be released closer to the event date.

June 19: World Sickle Cell Day
World Sickle Cell Day is observed annually with the goal to increase public knowledge and an understanding of sickle cell disease, and the challenges experienced by patients and their families and caregivers.

September 1 - 30: National Sickle Cell Awareness Month
National Sickle Cell Awareness Month is observed in September to raise awareness about SCD and the challenges faced by those living with it. This month focuses on increasing understanding of SCD, promoting research, and supporting individuals and families affected by the condition.

Sickle Cell Disease and Gene Therapies Webinar Series

In observance of National Sickle Cell Awareness Month 2025, HHS OMH partnered with the HHS Office for Human Research Protections (OHRP) to host a two-part webinar series on sickle cell disease (SCD) and gene therapies.

Part 1—Trust, Clinical Trials, and Transformative Therapies: Ethical Pathways in Gene Therapy and Sickle Cell Disease

Download slides

Part 2—Innovations and Advances in Sickle Cell Disease Gene Therapies

Download slides

Managing SCD Complications

In people with SCD, red blood cells can become rigid and deform into a crescent or sickle shape. Sickled cells die early and often become lodged in small blood vessels, restricting blood flow, which can lead to serious health problems throughout the body. SCD-associated complications include anemia, acute and chronic pain, infections, pneumonia and acute chest syndrome, stroke, and kidney, liver, and heart disease.

Managing Risk Through a Healthy Lifestyle

Improving Outcomes Through Supportive Communities


Date Last Reviewed: May 2026